The contemporary immunoassays for HIV diagnosis: a concise overview

[1] do Nascimento WM, Machiavelli A, Ferreira LGE, Cruz Silveira L, de Azevedo SSD, Bello G, et al. Gut microbiome profiles and associated metabolic pathways in HIV-infected treatment-naïve patients. Cells. 2021; 10:385. doi: 10.3390/cells10020385 do NascimentoWM MachiavelliA FerreiraLGE Cruz SilveiraL de AzevedoSSD BelloG Gut microbiome profiles and associated metabolic pathways in HIV-infected treatment-naïve patients Cells. 2021 10 385 10.3390/cells10020385 Open DOISearch in Google Scholar

[2] Jain C, Sharma L, Advani U, Kumar M, Tak A, Jain M. A cross-sectional study of socio-demographic and clinical profile of HIV patients at ART plus centre, Sawai Man Singh Hospital, Jaipur, India. JID Health. 2021; 4:321–6. JainC SharmaL AdvaniU KumarM TakA JainM A cross-sectional study of socio-demographic and clinical profile of HIV patients at ART plus centre, Sawai Man Singh Hospital, Jaipur, India JID Health. 2021 4 321 6 Search in Google Scholar

[3] Seyoum E, Demissie M, Worku A, Mulu A, Abdissa A, Berhane Y. HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: a retrospective cross-sectional study. PLoS One. 2022; 17:e0267230. doi: 10.1371/journal.pone.0267230 SeyoumE DemissieM WorkuA MuluA AbdissaA BerhaneY HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: a retrospective cross-sectional study PLoS One. 2022 17 e0267230 10.1371/journal.pone.0267230 Open DOISearch in Google Scholar

[4] Abdullah, Ali S, Cançado FACQ, de Oliveira CAF. The emergence of monkeypox virus, new challenges to the healthcare settings in Pakistan. J Med Virol. 2023; 95:e27899. doi: 10.1002/jmv.27899 Abdullah AliS CançadoFACQ de OliveiraCAF The emergence of monkeypox virus, new challenges to the healthcare settings in Pakistan J Med Virol. 2023 95 e27899 10.1002/jmv.27899 Open DOISearch in Google Scholar

[5] Waris A, Atta UK, Ali M, Asmat A, Baset A. COVID-19 outbreak: current scenario of Pakistan. New Microbes New Infect. 2020; 35:100681. doi: 10.1016/j.nmni.2020.100681 WarisA AttaUK AliM AsmatA BasetA COVID-19 outbreak: current scenario of Pakistan New Microbes New Infect. 2020 35 100681 10.1016/j.nmni.2020.100681 Open DOISearch in Google Scholar

[6] Kek H, Laumaea A, Parise S, Poumbourios P, Hearps AC, Jaworowski A. Differential expression of HIV envelope epitopes on the surface of HIV-Infected macrophages and CD4⁺ T cells. Antiviral Res. 2021; 191:105085. doi: 10.1016/j.antiviral.2021.105085 KekH LaumaeaA PariseS PoumbouriosP HearpsAC JaworowskiA Differential expression of HIV envelope epitopes on the surface of HIV-Infected macrophages and CD4⁺ T cells Antiviral Res. 2021 191 105085 10.1016/j.antiviral.2021.105085 Open DOISearch in Google Scholar

[7] Malonga GA, Jary A, Leducq V, Moudiongui Mboungou Malanda D, Boumba ALM, Chicaud E, et al. Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, Congo. Sci Rep. 2021; 11:17442. doi: 10.1038/s41598-021-97070-4 MalongaGA JaryA LeducqV Moudiongui Mboungou MalandaD BoumbaALM ChicaudE Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, Congo Sci Rep. 2021 11 17442 10.1038/s41598-021-97070-4 Open DOISearch in Google Scholar

[8] Gray ER, Bain R, Varsaneux O, Peeling RW, Stevens MM, McKendry RA. p24 revisited: a landscape review of antigen detection for early HIV diagnosis. AIDS. 2018; 32:2089–102. GrayER BainR VarsaneuxO PeelingRW StevensMM McKendryRA p24 revisited: a landscape review of antigen detection for early HIV diagnosis AIDS. 2018 32 2089 102 Search in Google Scholar

[9] Alexander TS. Human immunodeficiency virus diagnostic testing: 30 years of evolution. Clin Vaccine Immunol. 2016; 23:249–53. AlexanderTS Human immunodeficiency virus diagnostic testing: 30 years of evolution Clin Vaccine Immunol. 2016 23 249 53 Search in Google Scholar

[10] Alemayehu AE. Analysis of HCV coinfections among newly diagnosed HIV cases in Germany. Publication server of Robert Koch Institue. 2021;1–154. AlemayehuAE Analysis of HCV coinfections among newly diagnosed HIV cases in Germany Publication server of Robert Koch Institue 2021 1 154 Search in Google Scholar

[11] Qiu X, Sokoll L, Duong Ly T, Coignard C, Eshleman SH, Mohr P, et al. An improved HIV antigen/antibody prototype assay for earlier detection of acute HIV infection. J Clin Virol. 2021; 145:105022. QiuX SokollL Duong LyT CoignardC EshlemanSH MohrP An improved HIV antigen/antibody prototype assay for earlier detection of acute HIV infection J Clin Virol. 2021 145 105022 Search in Google Scholar

[12] Adetunji AA, Adewumi MO, Michael OS, Fayemiwo SA, Ogunniyi A, Taiwo BO. Rapid HIV antigen–antibody assays and detection of acute HIV infection in Sub-Saharan Africa. Am J Trop Med Hyg. 2019; 101:285–6. AdetunjiAA AdewumiMO MichaelOS FayemiwoSA OgunniyiA TaiwoBO Rapid HIV antigen–antibody assays and detection of acute HIV infection in Sub-Saharan Africa Am J Trop Med Hyg. 2019 101 285 6 Search in Google Scholar

[13] Tavakoli A, Karbalaie Niya MH, Keshavarz M, Ghaffari H, Asoodeh A, Monavari SH, et al. Current diagnostic methods for HIV. Future Virol. 2017; 12:141–55. TavakoliA Karbalaie NiyaMH KeshavarzM GhaffariH AsoodehA MonavariSH Current diagnostic methods for HIV Future Virol. 2017 12 141 55 Search in Google Scholar

[14] Ali M, Nadeem M, Numan M, Khalil AT, Maqbool K, Yousaf MZ, et al. Thirty years of HIV in Pakistan: a systematic review of prevalence and current scenario. Future Virol. 2017; 12:609–23. AliM NadeemM NumanM KhalilAT MaqboolK YousafMZ Thirty years of HIV in Pakistan: a systematic review of prevalence and current scenario Future Virol. 2017 12 609 23 Search in Google Scholar

[15] Haq I, Ullah R, Din M, Ahmad S, Anwar F, Ali M, Khan HU. Unrecognized HIV infection in asymptomatic volunteer blood donors at district Peshawar, Khyber Pakhtunkhwa, Pakistan. New Microbes New Infect. 2020; 35:100685. doi: 10.1016/j.nmni.2020.100685 HaqI UllahR DinM AhmadS AnwarF AliM KhanHU Unrecognized HIV infection in asymptomatic volunteer blood donors at district Peshawar, Khyber Pakhtunkhwa, Pakistan New Microbes New Infect. 2020 35 100685 10.1016/j.nmni.2020.100685 Open DOISearch in Google Scholar

[16] Barik SK, Mohanty K, Bisht D, Joshi B, Jena S, Tripathy SP. An overview of enzyme immunoassay: the test generation assay in HIV/AIDS testing. J AIDS Clin Res. 2018; 9:1–5. BarikSK MohantyK BishtD JoshiB JenaS TripathySP An overview of enzyme immunoassay: the test generation assay in HIV/AIDS testing J AIDS Clin Res. 2018 9 1 5 Search in Google Scholar

[17] Sarcina L, Mangiatordi GF, Torricelli F, Bollella P, Gounani Z, Österbacka R, et al. Surface plasmon resonance assay for label-free and selective detection of HIV-1 p24 protein. Biosensors (Basel). 2021; 11:180. doi: 10.3390/bios11060180 SarcinaL MangiatordiGF TorricelliF BollellaP GounaniZ ÖsterbackaR Surface plasmon resonance assay for label-free and selective detection of HIV-1 p24 protein Biosensors (Basel). 2021 11 180 10.3390/bios11060180 Open DOISearch in Google Scholar

[18] Fitzgerald N, Cross M, O'Shea S, Fox J. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24. Sex Transm Infect. 2017; 93:100–1. FitzgeraldN CrossM O'SheaS FoxJ Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24 Sex Transm Infect. 2017 93 100 1 Search in Google Scholar

[19] Rashid A, Li K, Feng Y, Ahmad T, Getaneh Y, Yu Y, et al. HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis. Hum Vaccin Immunother. 2022; 18:2014733. doi: 10.1080/21645515.2021.2014733 RashidA LiK FengY AhmadT GetanehY YuY HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis Hum Vaccin Immunother. 2022 18 2014733 10.1080/21645515.2021.2014733 Open DOISearch in Google Scholar

[20] Santos-Pereira A, Magalhães C, Araújo PMM, Osório N. Evolutionary genetics of Mycobacterium tuberculosis and HIV-1: “the tortoise and the hare”. Microorganisms. 2021; 9:147. doi: 10.3390/microorganisms9010147 Santos-PereiraA MagalhãesC AraújoPMM OsórioN Evolutionary genetics of Mycobacterium tuberculosis and HIV-1: “the tortoise and the hare” Microorganisms. 2021 9 147 10.3390/microorganisms9010147 Open DOISearch in Google Scholar

[21] Qiu X, Sokoll L, Yip P, Elliott DJ, Dua R, Mohr P, et al. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens. J Clin Virol. 2017; 92:62–8. QiuX SokollL YipP ElliottDJ DuaR MohrP Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens J Clin Virol. 2017 92 62 8 Search in Google Scholar

[22] Ly TD, Plantier JC, Leballais L, Gonzalo S, Lemée V, Laperche S. The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection. J Clin Virol. 2012; 55:121–7. LyTD PlantierJC LeballaisL GonzaloS LeméeV LapercheS The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection J Clin Virol. 2012 55 121 7 Search in Google Scholar

[23] Duette G, Hiener B, Morgan H, Mazur FG, Mathivanan V, Horsburgh BA, et al. The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4⁺ T cells. J Clin Invest. 2022; 132:e154422. doi: 10.1172/JCI154422 DuetteG HienerB MorganH MazurFG MathivananV HorsburghBA The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4⁺ T cells J Clin Invest. 2022 132 e154422 10.1172/JCI154422 Open DOISearch in Google Scholar

[24] Pai NP, Karellis A, Kim J, Peter T. Modern diagnostic technologies for HIV. Lancet HIV. 2020; 7:e574–81. PaiNP KarellisA KimJ PeterT Modern diagnostic technologies for HIV Lancet HIV. 2020 7 e574 81 Search in Google Scholar

[25] Curtis KA, Rudolph DL, Pan Y, Delaney K, Anastos K, DeHovitz J, et al. Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection. PloS one. 2021; 16:e0242641. CurtisKA RudolphDL PanY DelaneyK AnastosK DeHovitzJ Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection PloS one. 2021 16 e0242641 Search in Google Scholar

[26] Rossetti R, Smith T, Luo W, Masciotra S. Performance evaluation of the MedMira reveal G4 LAB S/P and POC HIV antibody rapid screening tests using plasma and whole blood specimens. J Clin Virol. 2020; 127:104344. RossettiR SmithT LuoW MasciotraS Performance evaluation of the MedMira reveal G4 LAB S/P and POC HIV antibody rapid screening tests using plasma and whole blood specimens J Clin Virol. 2020 127 104344 Search in Google Scholar

[27] Petersen J, Monteiro M, Dalal S, Jhala D. Reducing false-positive results with fourth-generation HIV testing at a veterans affairs medical center. Fed Pract. 2021; 38:232–7. PetersenJ MonteiroM DalalS JhalaD Reducing false-positive results with fourth-generation HIV testing at a veterans affairs medical center Fed Pract. 2021 38 232 7 Search in Google Scholar

[28] Pumarola T, Freeman J, Saxton E, Dillon P, Bal T, van Helden J. Performance evaluation of the ADVIA centaur(®) HIV Ag/Ab combo assay. J Virol Methods. 2010; 170:16–20. PumarolaT FreemanJ SaxtonE DillonP BalT van HeldenJ Performance evaluation of the ADVIA centaur(®) HIV Ag/Ab combo assay J Virol Methods. 2010 170 16 20 Search in Google Scholar

[29] Ly TD, Laperche S, Brennan C, Vallari A, Ebel A, Hunt J, et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods. 2004; 122:185–94. LyTD LapercheS BrennanC VallariA EbelA HuntJ Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays J Virol Methods. 2004 122 185 94 Search in Google Scholar

[30] Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods. 2007; 143:86–94. LyTD EbelA FaucherV FihmanV LapercheS Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods. 2007 143 86 94 Search in Google Scholar

[31] Weber B, Gürtler L, Thorstensson R, Michl U, Mühlbacher A, Bürgisser P, et al. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol. 2002; 40:1938–46. WeberB GürtlerL ThorstenssonR MichlU MühlbacherA BürgisserP Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity J Clin Microbiol. 2002 40 1938 46 Search in Google Scholar

[32] Weber B, Orazi B, Raineri A, Thorstensson R, Bürgisser P, Mühlbacher A, et al. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin Lab. 2006; 52:463–73. WeberB OraziB RaineriA ThorstenssonR BürgisserP MühlbacherA Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi Clin Lab. 2006 52 463 73 Search in Google Scholar

[33] Alonso R, López Roa P, Suárez M, Bouza E. New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies. J Clin Microbiol. 2014; 52:1467–70. AlonsoR López RoaP SuárezM BouzaE New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies J Clin Microbiol. 2014 52 1467 70 Search in Google Scholar

[34] Mariaggi AA, Gardiennet E, Stefic K, Essat A, Cheret A, Goujard C, et al. Immunoblots may not be effective in confirming the recency of HIV-1 infection. J Virol Methods. 2021; 290:114074. doi: 10.1016/j.jviromet.2021.114074 MariaggiAA GardiennetE SteficK EssatA CheretA GoujardC Immunoblots may not be effective in confirming the recency of HIV-1 infection J Virol Methods. 2021 290 114074 10.1016/j.jviromet.2021.114074 Open DOISearch in Google Scholar

[35] Liu P, Tang L, Kong WH, Zhu ZR, Xiao P, Wang X, et al. Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012–2018. PLoS One. 2020; 15:e0238282. doi: 10.1371/journal.pone.0238282 LiuP TangL KongWH ZhuZR XiaoP WangX Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012–2018 PLoS One. 2020 15 e0238282 10.1371/journal.pone.0238282 Open DOISearch in Google Scholar

[36] Hawthorne Hallen A, Samuelson A, Nordin M, Albert J, Bogdanovic G. Evaluation of bio-rad Geenius HIV-1 and-2 assay as a confirmatory assay for detection of HIV-1 and-2 antibodies. Clin Vaccine Immunol. 2014; 21:1192–4. Hawthorne HallenA SamuelsonA NordinM AlbertJ BogdanovicG Evaluation of bio-rad Geenius HIV-1 and-2 assay as a confirmatory assay for detection of HIV-1 and-2 antibodies Clin Vaccine Immunol. 2014 21 1192 4 Search in Google Scholar

[37] Thai KTD, Götz H, Slingerland BCGC, Klaasse J, Schutten M, Geurtsvan Kessel CH. An analysis of the predictive value of the HIV Ag/Ab screening assay within the performance characteristics of the DiaSorin LIAISON XL for the detection of blood-borne viruses. J Clin Virol. 2018; 102:95–100. ThaiKTD GötzH SlingerlandBCGC KlaasseJ SchuttenM Geurtsvan KesselCH An analysis of the predictive value of the HIV Ag/Ab screening assay within the performance characteristics of the DiaSorin LIAISON XL for the detection of blood-borne viruses J Clin Virol. 2018 102 95 100 Search in Google Scholar

[38] Zeytinoğlu A, Kayın M, Altuğlu İ, Gökengin D, Sertöz R. Comparison of two anti-HIV confirmatory assays: recombinant HIV 1/2 line immunoassay and geenius HIV 1/2 confirmatory test. Mikrobiyol Bul. 2020; 54:613–8. ZeytinoğluA KayınM Altuğluİ GökenginD SertözR Comparison of two anti-HIV confirmatory assays: recombinant HIV 1/2 line immunoassay and geenius HIV 1/2 confirmatory test Mikrobiyol Bul. 2020 54 613 8 Search in Google Scholar

[39] Cdc.gov. Types of HIV tests | testing | HIV basics | HIV/AIDS | CDC. [Internet]. 2020. [cited 2021 Dec 5] Available from: https://www.cdc.gov/hiv/basics/hiv-testing/test-types.html Cdc.gov. Types of HIV tests | testing | HIV basics | HIV/AIDS | CDC. [Internet]. 2020. [cited 2021 Dec 5] Available from: https://www.cdc.gov/hiv/basics/hiv-testing/test-types.html Search in Google Scholar

[40] Jagodzinski LL, Manak MM, Hack HR, Liu Y, Peel SA. Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA. PLoS One. 2020; 15:e0229424. doi: 10.1371/journal.pone.0229424 JagodzinskiLL ManakMM HackHR LiuY PeelSA Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA PLoS One. 2020 15 e0229424 10.1371/journal.pone.0229424 Open DOISearch in Google Scholar

[41] Bakkour S, Deng X, Bacchetti P, Grebe E, Montalvo L, Worlock A, et al. Replicate aptima assay for quantifying residual plasma viremia in individuals on antiretroviral therapy. J Clin Microbiol. 2020; 58:e01400–20. BakkourS DengX BacchettiP GrebeE MontalvoL WorlockA Replicate aptima assay for quantifying residual plasma viremia in individuals on antiretroviral therapy J Clin Microbiol. 2020 58 e01400 20 Search in Google Scholar

[42] Patel P, Raizes E, Broyles LN. Human immunodeficiency virus infection. In Hunter's Tropical Medicine and Emerging Infectious Diseases (Tenth Edition). Elsevier. 2020;232–66. PatelP RaizesE BroylesLN Human immunodeficiency virus infection In Hunter's Tropical Medicine and Emerging Infectious Diseases Tenth Edition Elsevier 2020 232 66 Search in Google Scholar

[43] Sharma P, Batheja G, Verma HN, Seth P. Development of a novel molecular assay based on conventional PCR liquid hybridization and ELISA (NAT-ELISA) for the detection of HIV, HCV, and HBV in blood donors. Indian J Med Microbiol. 2022; 40:122–6. SharmaP BathejaG VermaHN SethP Development of a novel molecular assay based on conventional PCR liquid hybridization and ELISA (NAT-ELISA) for the detection of HIV, HCV, and HBV in blood donors Indian J Med Microbiol. 2022 40 122 6 Search in Google Scholar

[44] Naz F, Siddique YH. Nanotechnology: its application in treating neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2021; 20:34–53. NazF SiddiqueYH Nanotechnology: its application in treating neurodegenerative diseases CNS Neurol Disord Drug Targets. 2021 20 34 53 Search in Google Scholar

[45] Farzin L, Shamsipur M, Samandari L, Sheibani S. HIV biosensors for early diagnosis of infection: the intertwine of nanotechnology with sensing strategies. Talanta. 2020; 206:120201. doi: 10.1016/j.talanta.2019.120201 FarzinL ShamsipurM SamandariL SheibaniS HIV biosensors for early diagnosis of infection: the intertwine of nanotechnology with sensing strategies Talanta. 2020 206 120201 10.1016/j.talanta.2019.120201 Open DOISearch in Google Scholar

[46] Hammou RA, Benhassou M, Ennaji MM. Application of nanodiagnostics in viral infectious diseases. In Emerging and Reemerging Viral Pathogens. Academic Press. 2020;179–95. HammouRA BenhassouM EnnajiMM Application of nanodiagnostics in viral infectious diseases In Emerging and Reemerging Viral Pathogens Academic Press 2020 179 95 Search in Google Scholar

[47] Mozhgani SH, Kermani HA, Norouzi M, Arabi M, Soltani S. Nanotechnology based strategies for HIV-1 and HTLV-1 retroviruses gene detection. Heliyon. 2020; 27:e04048. MozhganiSH KermaniHA NorouziM ArabiM SoltaniS Nanotechnology based strategies for HIV-1 and HTLV-1 retroviruses gene detection Heliyon. 2020 27 e04048 Search in Google Scholar

[48] Parekh BS, Ou CY, Fonjungo PN, Kalou MB, Rottinghaus E, Puren A, et al. Diagnosis of human immunodeficiency virus infection. Clin Microbiol Rev. 2018; 32:e00064–18. ParekhBS OuCY FonjungoPN KalouMB RottinghausE PurenA Diagnosis of human immunodeficiency virus infection Clin Microbiol Rev. 2018 32 e00064 18 Search in Google Scholar

[49] Dhal A, Kalyani T, Ghorai S, Sahu NK, Jana SK. Recent development of electrochemical immunosensor for the diagnosis of dengue virus NSI protein: a review. Sens Int. 2020; 1:100030. DhalA KalyaniT GhoraiS SahuNK JanaSK Recent development of electrochemical immunosensor for the diagnosis of dengue virus NSI protein: a review Sens Int. 2020 1 100030 Search in Google Scholar

[50] Tang S, Hewlett I. Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J Infect Dis. 2010; 201(Supplement_1):S59–64. TangS HewlettI Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen J Infect Dis. 2010 201 Supplement_1 S59 64 Search in Google Scholar

[51] Abbaszadeh S, Rashidipour M, Khosravi P, Shahryarhesami S, Ashrafi B, Kaviani M, Moradi Sarabi M. Biocompatibility, cytotoxicity, antimicrobial and epigenetic effects of novel chitosan-based quercetin nanohydrogel in human cancer cells. Int J Nanomedicine. 2020; 15:5963–75. AbbaszadehS RashidipourM KhosraviP ShahryarhesamiS AshrafiB KavianiM Moradi SarabiM Biocompatibility, cytotoxicity, antimicrobial and epigenetic effects of novel chitosan-based quercetin nanohydrogel in human cancer cells Int J Nanomedicine. 2020 15 5963 75 Search in Google Scholar

[52] Zhang L, Mazouzi Y, Salmain M, Liedberg B, Boujday S. Antibodygold nanoparticle bioconjugates for biosensors: synthesis, characterization and selected applications. Biosens Bioelectron. 2020; 165:112370. doi: 10.1016/j.bios.2020.112370 ZhangL MazouziY SalmainM LiedbergB BoujdayS Antibodygold nanoparticle bioconjugates for biosensors: synthesis, characterization and selected applications Biosens Bioelectron. 2020 165 112370 10.1016/j.bios.2020.112370 Open DOISearch in Google Scholar

[53] Kong H, Zhang W, Yao J, Li C, Lu R, Guo Z, et al. A RT-LAMP based hydrogen ion selective electrode sensing for effective detection HIV-1 RNA with high-sensitivity. Sens Actuators B Chem. 2020; 329:129118. doi: 10.1016/j.snb.2020.129118 KongH ZhangW YaoJ LiC LuR GuoZ A RT-LAMP based hydrogen ion selective electrode sensing for effective detection HIV-1 RNA with high-sensitivity Sens Actuators B Chem. 2020 329 129118 10.1016/j.snb.2020.129118 Open DOISearch in Google Scholar

[54] Yadav S, Senapati S, Desai D, Gahlaut S, Kulkarni S, Singh JP. Portable and sensitive Ag nanorods based SERS platform for rapid HIV-1 detection and tropism determination. Colloids Surf B Biointerfaces. 2021; 198:111477. doi: 10.1016/j.colsurfb.2020.111477 YadavS SenapatiS DesaiD GahlautS KulkarniS SinghJP Portable and sensitive Ag nanorods based SERS platform for rapid HIV-1 detection and tropism determination Colloids Surf B Biointerfaces. 2021 198 111477 10.1016/j.colsurfb.2020.111477 Open DOISearch in Google Scholar

[55] Gray ER, Turbé V, Lawson VE, Page RH, Cook ZC, Ferns RB, et al. Ultra-rapid, sensitive and specific digital diagnosis of HIV with a dual-channel SAW biosensor in a pilot clinical study. NPJ Digit Med. 2018; 1:35. doi: 10.1038/s41746-018-0041-5 GrayER TurbéV LawsonVE PageRH CookZC FernsRB Ultra-rapid, sensitive and specific digital diagnosis of HIV with a dual-channel SAW biosensor in a pilot clinical study NPJ Digit Med. 2018 1 35 10.1038/s41746-018-0041-5 Open DOISearch in Google Scholar

[56] Tran VT, Nguyen H-Q, Kim Y-M, Ok G, Lee J. Photonic–plasmonic nanostructures for solar energy utilization and emerging biosensors. Nanomaterials (Basel). 2020; 10:2248. doi: 10.3390/nano10112248 TranVT NguyenH-Q KimY-M OkG LeeJ Photonic–plasmonic nanostructures for solar energy utilization and emerging biosensors Nanomaterials (Basel). 2020 10 2248 10.3390/nano10112248 Open DOISearch in Google Scholar

[57] Bonyar A. Label-free nucleic acid biosensing using nanomaterial-based localized surface plasmon resonance imaging: a review. ACS Appl Nano Mater. 2020; 3:8506–21. BonyarA Label-free nucleic acid biosensing using nanomaterial-based localized surface plasmon resonance imaging: a review ACS Appl Nano Mater. 2020 3 8506 21 Search in Google Scholar

[58] Inci F, Karaaslan MG, Mataji-Kojouri A, Shah PA, Saylan Y, Zeng Y, et al. Enhancing the nanoplasmonic signal by a nanoparticle sandwiching strategy to detect viruses. Appl Mater Today. 2020; 20:100709. doi: 10.1016/j.apmt.2020.100709 InciF KaraaslanMG Mataji-KojouriA ShahPA SaylanY ZengY Enhancing the nanoplasmonic signal by a nanoparticle sandwiching strategy to detect viruses Appl Mater Today. 2020 20 100709 10.1016/j.apmt.2020.100709 Open DOISearch in Google Scholar

[59] Palmer S, Dijkstra M, Ket JC, Wahome EW, Walimbwa J, Gichuru E, et al. Acute and early HIV infection screening among men who have sex with men, a systematic review and meta-analysis. J Int AIDS Soc. 2020; 23:e25590. doi: 10.1002/jia2.25590 PalmerS DijkstraM KetJC WahomeEW WalimbwaJ GichuruE Acute and early HIV infection screening among men who have sex with men, a systematic review and meta-analysis J Int AIDS Soc. 2020 23 e25590 10.1002/jia2.25590 Open DOISearch in Google Scholar

[60] Leyre L, Kroon E, Vandergeeten C, Sacdalan C, Colby DJ, Buranapraditkun S, et al. Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection. Sci Transl Med. 2020; 12:eaav3491. doi: 10.1126/scitranslmed.aav3491 LeyreL KroonE VandergeetenC SacdalanC ColbyDJ BuranapraditkunS Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection Sci Transl Med. 2020 12 eaav3491 10.1126/scitranslmed.aav3491 Open DOISearch in Google Scholar

[61] Peruski AH, Wesolowski LG, Delaney KP, Chavez PR, Owen SM, Granade TC, et al. Trends in HIV-2 diagnoses and use of the HIV-1/HIV-2 differentiation test – United States, 2010–2017. MMWR Morb Mortal Wkly Rep. 2020; 69:63–6. PeruskiAH WesolowskiLG DelaneyKP ChavezPR OwenSM GranadeTC Trends in HIV-2 diagnoses and use of the HIV-1/HIV-2 differentiation test – United States, 2010–2017 MMWR Morb Mortal Wkly Rep. 2020 69 63 6 Search in Google Scholar

[62] Laracy J, Zucker J. The role of human immunodeficiency virus molecular diagnostics in ending the epidemic. Adv Mol Path. 2020; 3:97–105. LaracyJ ZuckerJ The role of human immunodeficiency virus molecular diagnostics in ending the epidemic Adv Mol Path. 2020 3 97 105 Search in Google Scholar

[63] Rinaldi F, Rolla S, Galli L, Poli A, Muccini C, Mastrangelo A, et al. Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection. New Microbiol. 2020; 43:55–7. RinaldiF RollaS GalliL PoliA MucciniC MastrangeloA Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection New Microbiol. 2020 43 55 7 Search in Google Scholar

[64] Gay CL, Neo DT, Devanathan AS, Kuruc JD, McGee KS, Schmitz JL, et al. Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection. Aids. 2020; 34:1923–31. GayCL NeoDT DevanathanAS KurucJD McGeeKS SchmitzJL Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection Aids. 2020 34 1923 31 Search in Google Scholar

[65] Puthanakit T, Ananworanich J, Akapirat S, Pattanachaiwit S, Ubolyam S, Assawadarachai V, et al. Pattern and frequency of seroreactivity to routinely used serologic tests in early-treated infants with HIV. J Acquir Immune Defic Syndr. 2020; 83:260–6. PuthanakitT AnanworanichJ AkapiratS PattanachaiwitS UbolyamS AssawadarachaiV Pattern and frequency of seroreactivity to routinely used serologic tests in early-treated infants with HIV J Acquir Immune Defic Syndr. 2020 83 260 6 Search in Google Scholar

[66] Branson BM, Owen SM, Wesolowski LG, Bennett B, Werner BG, Wroblewski KE, Pentella MA. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014. BransonBM OwenSM WesolowskiLG BennettB WernerBG WroblewskiKE PentellaMA Laboratory testing for the diagnosis of HIV infection: updated recommendations 2014 Search in Google Scholar

[67] Loynachan CN, Thomas MR, Gray ER, Richards DA, Kim J, Miller BS, et al. Platinum nanocatalyst amplification: redefining the gold standard for lateral flow immunoassays with ultrabroad dynamic range. ACS Nano. 2018; 12:279–88. LoynachanCN ThomasMR GrayER RichardsDA KimJ MillerBS Platinum nanocatalyst amplification: redefining the gold standard for lateral flow immunoassays with ultrabroad dynamic range ACS Nano. 2018 12 279 88 Search in Google Scholar

[68] Parpia ZA, Elghanian R, Nabatiyan A, Hardie DR, Kelso DM. p24 antigen rapid test for diagnosis of acute pediatric HIV infection. J AIDS. 2010; 55:413–9. ParpiaZA ElghanianR NabatiyanA HardieDR KelsoDM p24 antigen rapid test for diagnosis of acute pediatric HIV infection J AIDS. 2010 55 413 9 Search in Google Scholar

[69] Nabatiyan A, Baumann MA, Parpia Z, Kelso D. A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles. J AIDS. 2010; 53:55–61. NabatiyanA BaumannMA ParpiaZ KelsoD A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles J AIDS. 2010 53 55 61 Search in Google Scholar

[70] Nandi S, Mondal A, Roberts A, Gandhi S. Biosensor platforms for rapid HIV detection. Adv Clin Chem. 2020; 98:1–34. NandiS MondalA RobertsA GandhiS Biosensor platforms for rapid HIV detection Adv Clin Chem. 2020 98 1 34 Search in Google Scholar

[71] De La Rica R, Stevens MM. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat Nanotechnol. 2012; 7821–4. De La RicaR StevensMM Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye Nat Nanotechnol. 2012 7821 4 Search in Google Scholar

[72] Vallooran JJ, Handschin S, Pillai SM, Vetter BN, Rusch S, Beck HP, Mezzenga R. Lipidic cubic phases as a versatile platform for the rapid detection of biomarkers, viruses, bacteria, and parasites. Adv Funct Mater. 2016; 26:181–90. VallooranJJ HandschinS PillaiSM VetterBN RuschS BeckHP MezzengaR Lipidic cubic phases as a versatile platform for the rapid detection of biomarkers, viruses, bacteria, and parasites Adv Funct Mater. 2016 26 181 90 Search in Google Scholar

[73] Cretich M, Daaboul GG, Sola L, Ünlü MS, Chiari M. Digital detection of biomarkers assisted by nanoparticles: application to diagnostics. Trends Biotechnol. 2015; 33:343–51. CretichM DaaboulGG SolaL ÜnlüMS ChiariM Digital detection of biomarkers assisted by nanoparticles: application to diagnostics Trends Biotechnol. 2015 33 343 51 Search in Google Scholar

[74] Ran P, Song J, Mo F, Wu J, Liu P, Fu Y. Nitrogen-doped graphene quantum dots coated with gold nanoparticles for electrochemiluminescent glucose detection using enzymatically generated hydrogen peroxide as a quencher. Microchimica Acta. 2019; 186:1–7. RanP SongJ MoF WuJ LiuP FuY Nitrogen-doped graphene quantum dots coated with gold nanoparticles for electrochemiluminescent glucose detection using enzymatically generated hydrogen peroxide as a quencher Microchimica Acta. 2019 186 1 7 Search in Google Scholar